AC Immune SA (ACIU)
NASDAQ: ACIU · Real-Time Price · USD
3.240
-0.030 (-0.92%)
Nov 20, 2024, 4:00 PM EST - Market closed
AC Immune Employees
As of December 31, 2023, AC Immune had 161 total employees, including 133 full-time and 28 part-time employees. The number of employees increased by 5 or 3.21% compared to the previous year.
Employees
161
Change (1Y)
5
Growth (1Y)
3.21%
Revenue / Employee
$301,276
Profits / Employee
-$293,114
Market Cap
320.57M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Cerus | 637 |
Lyell Immunopharma | 224 |
Alpha Teknova | 211 |
COMPASS Pathways | 186 |
Codexis | 174 |
Absci | 155 |
Nyxoah | 147 |
Sanara MedTech | 108 |
ACIU News
- 6 days ago - AC Immune's Active Immunotherapy Shows Antibody Responses In Early Parkinson's Patients - Benzinga
- 4 months ago - AC Immune Unveils Novel Therapeutic Antibody Drug Conjugate (ADC) Technology for Improved Efficacy in Neurodegenerative Diseases at AAIC 2024 - GlobeNewsWire
- 4 months ago - AC Immune: Takeda Partnership Brings Funds To Drive Pipeline Forward - Seeking Alpha
- 4 months ago - AC Immune's ACI-35.030 (now “JNJ-2056”) Granted FDA Fast Track Designation for Alzheimer's Disease - GlobeNewsWire
- 6 months ago - AC Immune to Present at the Jefferies Global Healthcare Conference in June 2024 - GlobeNewsWire
- 6 months ago - Alzheimer's vaccine licensing deal boosts AC Immune - Market Watch
- 6 months ago - AC Immune Reports First Quarter 2024 Financial Results and Provides a Corporate Update - GlobeNewsWire
- 6 months ago - AC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting Amyloid Beta for Alzheimer's Disease - Business Wire